Information on EC 3.4.21.94 - proprotein convertase 2:

   PRINT
Please wait a moment until all data are loaded. This message will disappear when all data are loaded.
Mark a special word or phrase in this record:  
Select one or more organisms in this record:

Show additional data Do not include text mining results
Include (text mining) results (more...)
Include results (AMENDA + additional results, but less precise; more...)

Please login to have access to the AMENDA and FRENDA data

EC NUMBERCOMMENTARY
3.4.21.94-

RECOMMENDED NAMEGeneOntology No.
proprotein convertase 2GO:0004286

REACTIONREACTION DIAGRAMCOMMENTARYORGANISM UNIPROT ACCESSION NO.LITERATURE
release of protein hormones and neuropeptides from their precursors, generally by hydrolysis of -Lys-Arg-/- bonds
show the reaction diagram
----
release of protein hormones and neuropeptides from their precursors, generally by hydrolysis of -Lys-Arg-/- bonds
show the reaction diagram
the catalytic triad is formed by the conserved residues Asp169, His210, and Ser386Oryzias latipes-668720
release of protein hormones and neuropeptides from their precursors, generally by hydrolysis of -Lys-Arg-/- bonds
show the reaction diagram
active site and substrate binding structure, enzyme-substrate interactions at prime and non-prime subsitesHomo sapiens-669843

REACTION TYPEORGANISM UNIPROT ACCESSION NO.COMMENTARYLITERATURE
hydrolysis of peptide bond----

PATHWAYKEGG LinkMetaCyc Link
No entries in this field

SYSTEMATIC NAMEIUBMB Comments
No entries in this field

SYNONYMSORGANISM UNIPROT ACCESSION NO.COMMENTARYLITERATURE
Neuroendocrine convertase 2----
PC2----
PC2Homo sapiens--653858, 668083, 669843, 682808, 688466, 717906
PC2Mus musculus--653858, 668377, 668422, 669378, 669436, 670480, 677957, 686302, 686303, 688466, 688525, 689212, 700298, 709603, 717856
PC2Rattus norvegicus--653858, 669626, 683932, 688466, 689214, 700473, 709250, 710101
PC2Oryzias latipes--668720
PC2Haliotis asininaB2ZSS9-708778
PC2-like enzymeHaliotis asininaB2ZSS9-708778
PCSK2Homo sapiens--689018
pro-protein convertase-2Rattus norvegicus--710101
pro-protein convertase-2/carboxypeptidase-ERattus norvegicus--710101
Prohormone convertaseMus musculus--669378
prohormone convertase 12Mus musculus--669436
prohormone convertase 2Mus musculus--653858, 668377, 670480, 677957, 686302, 686303, 717856
prohormone convertase 2Rattus norvegicus--653858, 669626, 683932
prohormone convertase 2Homo sapiens--653858, 682808, 717906
prohormone convertase 2Haliotis asininaB2ZSS9-708778
prohormone convertase-2Mus musculus--688525, 709603
proneuropeptide convertase 2Mus musculus--689212
proprotein convertase 2Rattus norvegicus--689214, 709250
proprotein convertase subtilisin/kexin-type 2Homo sapiens--689018
EGL-3/KPC2Caenorhabditis elegans--688526
additional informationMus musculus-the enzyme belongs to the proprotein protease family of mammalian calcium-dependent serine proteases669378

CAS REGISTRY NUMBERCOMMENTARY
130960-94-0-
130960-95-1-
388092-42-0-

ORGANISMCOMMENTARYLITERATURESEQUENCE CODESEQUENCE DB SOURCE
Caenorhabditis elegansstrain N2, variety Bristol688526--Manually annotated by BRENDA team
Caenorhabditis elegans N2strain N2, variety Bristol688526--Manually annotated by BRENDA team
Haliotis asininacollected from Heron Island Reef, Great Barrier Reef, Australia, gene PC2 encodes a PC2-like enzyme708778B2ZSS9UniProtManually annotated by BRENDA team
Homo sapiens-29417, 29874, 29877, 668083, 669843, 682808, 688466, 689018, 717906--Manually annotated by BRENDA team
Homo sapienshuman653858--Manually annotated by BRENDA team
Mammalia-29875--Manually annotated by BRENDA team
Mus musculus-668377, 668422, 669378, 669436, 670480, 677957, 686302, 688466, 688525, 700298, 717856--Manually annotated by BRENDA team
Mus musculusCD-1 genetic background689212--Manually annotated by BRENDA team
Mus musculusCD-1 mice and C57B/6 mice686303--Manually annotated by BRENDA team
Mus musculuslittermate mice709603--Manually annotated by BRENDA team
Mus musculusmouse651892, 651913--Manually annotated by BRENDA team
Mus musculusmouse, AtT-20 cells651994, 653858--Manually annotated by BRENDA team
Mus musculusmouse, strain CD-1651008--Manually annotated by BRENDA team
Oryzias latipesmedaka668720--Manually annotated by BRENDA team
Rattus norvegicus-688466, 689214, 700473, 709250, 710101--Manually annotated by BRENDA team
Rattus norvegicusadult male Sprague-Dawley rats683932--Manually annotated by BRENDA team
Rattus norvegicusmale sprague-dawley rats669626--Manually annotated by BRENDA team
Rattus norvegicusrat, Sprague-Dawley651913, 653858--Manually annotated by BRENDA team

GENERAL INFORMATIONORGANISM UNIPROT ACCESSION NO.COMMENTARYLITERATURE
malfunctionRattus norvegicus-PC2 activity is reduced in ischemic brains, brain ischemia attenuates PC2 and PC2-mediated neuropeptide processing. This attenuation may play a role in the pathology of ischemic brain injury. Intracerebroventricular administration of synthetic PC2 substrate dynorphin-A(1-8) significantly reduces the extent of ischemic brain injury, overview709250
metabolismHaliotis asininaB2ZSS9prohormone convertase 2 belongs to a family of enzymes involved in the proteolytic maturation of neuropeptide precursors into mature peptides that act as neurotransmitters, neuromodulators or neurohormones708778
physiological functionRattus norvegicus-PC2 mediates neuropeptide processing in the brain709250
physiological functionMus musculus-PC2 functions in the generation of neuropeptides from their precursors, of neuropeptides/secretory pathway proteins, quantitative peptidomics, overview. Role of PC2 in the processing of peptides in a variety of brain regions709603
physiological functionRattus norvegicus-PC2 is required for the neuropeptide pro-protein processing system710101
physiological functionMus musculus-proglucagon cleavage has a greater dependence on PC2 activity than other precursors (e.g. proopiomelanocortin) and 7B2-dependent routing of PC2 to secretory granules is cell line-specific717856
physiological functionHomo sapiens-PC2 expression and Akt phosphorylation are related at the molecular level, resulting in a change in cell cycle and an increase in pituitary adenoma size717906

SUBSTRATEPRODUCT                      REACTION DIAGRAMORGANISM UNIPROT ACCESSION NO. COMMENTARY/
Substrate
LITERATURE/
Substrate
COMMENTARY/
Product
LITERATURE/
Product
Reversibility
r=reversible
ir=irreversible
?=not specified
2-aminobenzoyl-LPSDEEGESYKEVPEMEKRYGGFMQ-N-(2,4-dinitrophenyl)ethylenediamine + H2O?
show the reaction diagram
Mus musculus--651892-651892?
2-aminobenzoyl-Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-N-(2,4-dinitrophenyl)ethylenediamine + H2O?
show the reaction diagram
Mus musculus--651892-651892?
2-aminobenzoyl-Val-Pro-Arg-Met-Glu-Lys-Arg-Tyr-Gly-Gly-Phe-Met-Gln-N-(2,4-dinitrophenyl)ethylenediamine + H2O?
show the reaction diagram
Mus musculus--651892-651892?
Ac-Arg-Phe-Ala-Arg-4-methylcoumarin 7-amide + H2O?
show the reaction diagram
Mus musculus--651892-651892?
Ac-Arg-Pro-Lys-Arg-4-methylcoumarin 7-amide + H2O?
show the reaction diagram
Mus musculus--651892-651892?
Ac-Lys-Ser-Lys-Arg-4-methylcoumarin 7-amide + H2O?
show the reaction diagram
Mus musculus--651892-651892?
Ac-Orn-Ser-Lys-Arg-4-methylcoumarin 7-amide + H2O?
show the reaction diagram
Mus musculus--651892-651892?
Boc-Gly-Arg-Arg-4-methylcoumarin 7-amide + H2O?
show the reaction diagram
Mus musculus--651892-651892?
Boc-Gly-Lys-Arg-4-methylcoumarin 7-amide + H2O?
show the reaction diagram
Mus musculus--651892-651892?
Boc-Val-Pro-Arg-4-methylcoumarin 7-amide + H2O?
show the reaction diagram
Mus musculus--651892-651892?
CBZ-Arg-Ser-Lys-Arg-4-methylcoumarin 7-amide + H2O?
show the reaction diagram
Mus musculus--651892-651892?
Cbz-Arg-Ser-Lys-Arg-aminomethylcoumarin + H2O?
show the reaction diagram
Mus musculus--651913-651913?
cholecystokinin 8-containing peptide + H2O?
show the reaction diagram
Mus musculus-a synthetic peptide substrate containing the CCK 8 Gly Arg Arg peptide sequence, i.e. DYMGWMDF, and the cleavage site of pro-cholecystokinin for its liberation, overview670480--?
dynorphin A 1-17 + H2O?
show the reaction diagram
Mus musculus--651913-651913?
dynorphin AB 1-32 + H2O?
show the reaction diagram
Mus musculus--651913-651913?
dynorphin-A(1-8) + H2O?
show the reaction diagram
Rattus norvegicus--709250--?
glicentin1-69 + H2Oglucagon + glicentin-related polypeptide + GLP-1
show the reaction diagram
Mus musculus-glicentin lacks the signal sequence of proglucagon, residues -20-1, recombinant hamster substrate and murine enzyme co-expressed in rat GH4C1 cells, cleavage at the proglucagon interdomain site Lys70-Arg71-/-, at Lys31-Arg32-/-, and at -/-Lys62-Arg63668422mature glucagon consists of residues 33-61, glicentin-related polypeptide comprises the C-terminal residues 1-32, GLP-1 is the N-terminal glucagon-like peptide comprising residues 62-69-?
L-pGlu-Arg-Thr-Lys-Arg-7-amido-4-methylcoumarin + H2OL-pGlu-Arg-Thr-Lys-Arg + 7-amino-4-methylcoumarin
show the reaction diagram
Rattus norvegicus--709250--?
peptide B-derived peptides + H2O?
show the reaction diagram
Mus musculus-cleavage site specificity of wild-type and mutant PC2, overview669378--?
pGlu-Arg-Thr-Lys-Arg-4-methylcoumarin 7-amide + H2O?
show the reaction diagram
Mus musculus--651008-651008?
pGlu-Arg-Thr-Lys-Arg-4-methylcoumarin 7-amide + H2O?
show the reaction diagram
Mus musculus--651892-651892?
pGlu-Arg-Thr-Lys-Arg-4-methylcoumarin 7-amide + H2O?
show the reaction diagram
Mus musculus--653858-653858?
pro-cholecystokinin + H2ON-terminal propeptide + C-terminal cholecystokinin 8 Gly Arg Arg peptide + remaining CCK peptide
show the reaction diagram
Mus musculus-the substrate is only cleaved in vivo since defolding proteins are required, in vitro the cleavage site is inaccessible for the enzyme670480peptide product analysis-?
pro-cholecystokinin + H2ON-terminal propeptide + cholecystokinin 58
show the reaction diagram
Mus musculus-the substrate is only cleaved at the CKK 8 peptide in vivo since defolding proteins are required, in vitro the cleavage site is inaccessible for the enzyme670480peptide product analysis-?
pro-islet amyloid polypeptide + H2Oislet amyloid polypeptide processing intermediate + N-terminal pro-peptide
show the reaction diagram
Mus musculus-precursor of IAPP or amylin, the major component of islet amyloid, cleavage at the N-terminus, but not the C-terminus, which would also be required for activation, the complete activation is catalyzed by PC1, EC 3.4.21.93668377--?
pro-neurotensin/neuromedin N + H2Oneurotensin + neuromedin N
show the reaction diagram
Mus musculus, Homo sapiens, Rattus norvegicus--688466--?
Pro-opiomelanocortin + H2OOpiomelanocortin + ?
show the reaction diagram
Homo sapiens-from mouse and pig29874---
prodynorphin + H2Odynorphin + ?
show the reaction diagram
Homo sapiens-rat, cleavage at a single Arg residue, at a bond in which P2 is Thr29874---
prodynorphin + H2Odynorphin A 1-17 + dynorphin B 1-13 + alpha-neo-endorphin + C-peptide + dynorphin A 1-8 + ?
show the reaction diagram
Mus musculus--651913-651913?
Proenkephalin + H2OEnkephalin + ?
show the reaction diagram
Homo sapiens-human29874---
proenkephalin + H2Oopioid-active enkephalin + ?
show the reaction diagram
Mus musculus--651892-651892?
proenkephalin + H2Oopioid-active enkephalin + ?
show the reaction diagram
Mus musculus--651994-651994?
proenkephalin + H2Oopioid-active enkephalin + ?
show the reaction diagram
Mus musculus-cleaves prohormones and proneuropeptides from inactive large precursors to generate activre peptide for extracellular release651892-651892?
proenkphalin-derived peptide + H2O?
show the reaction diagram
Mus musculus-the preferred cleavage site sequence of PC2 is YGGFLKR-/-FAESL669378--?
Proglucagon + H2OGlucagon + ?
show the reaction diagram
Mammalia-dibasic cleavage sites29875-29875-
Proglucagon + H2O?
show the reaction diagram
Mus musculus--717856--?
Proglucagon + H2O?
show the reaction diagram
Mammalia-key endoprotease responsible for proglucagon processing in cells with the alpha-cell phenotype29875---
proglucagon + H2Oglucagon
show the reaction diagram
Mus musculus--686303--?
proglucagon1-158 + H2Oglucagon + glicentin-related polypeptide + GLP-1 + IP2/GLP-2
show the reaction diagram
Mus musculus-recombinant hamster substrate and murine enzyme co-expressed in rat GH4C1 cells, cleavage at the proglucagon interdomain site Lys70-Arg71-/-, at Lys31-Arg32-/-, and at -/-Lys62-Arg63668422mature glucagon consists of residues 33-61, glicentin-related polypeptide comprises the C-terminal residues 1-32, GLP-1 is the N-terminal glucagon-like peptide comprising residues 62-69, IP2/GLP-2 comprises residues 72-158-?
proIAPP + H2Omature IAPP
show the reaction diagram
Mus musculus-enhanced NH(2)-terminal processing of proIAPP by adenoviral expression of PC2, reducing (pro)IAPP-induced cell death in GH3 cells. Overexpression of PC2 in INS-1 beta-cells also enhances NH(2)-terminal processing of proIAPP686302--?
Proinsulin + H2OInsulin + ?
show the reaction diagram
Homo sapiens-selective cleavage only at the C peptide-A chain junction29417---
proPC2 + H2Omature PC2
show the reaction diagram
Mus musculus--677957--?
prothyrotropin-releasing hormone + H2Othyrotropin-releasing hormone + pro-peptide of thyrotropin-releasing hormone
show the reaction diagram
Rattus norvegicus-processing and activation of the inactive prohormone is required for regulation of energy balance via leptin, enzyme regulation, overview, processing of the prohormone669626--?
pyr-Glu-Arg-Thr-Lys-Arg-7-amido-4-methylcoumarin + H2O?
show the reaction diagram
Mus musculus--700298--?
somatostatin + H2O?
show the reaction diagram
Rattus norvegicus-PC2 may function as sorting element for somatostatin for its maturation and processing to appropiate targets683932--?
leumorphin + H2O?
show the reaction diagram
Mus musculus--651913-651913?
additional information?-Homo sapiens-cleavage specificity, cleaves precursors both at specific single and pairs of basic residues, not: prorenin, prosomatostatin29874---
additional information?-Mus musculus-prefers Arg at positions P4 and P5 in peptide B IQ substrates, Boc-Val-Leu-Lys-4-methylcoumarin 7-amide is no substrate651892-651892?
additional information?-Mammalia-present on secretory pathway of neuroendocrine cells29875---
additional information?-Homo sapiens-processing of precursors that are routed toward secretory granules29874---
additional information?-Mus musculus-glucose-dependent insulinotropic polypeptide precursor is no substrate of PC2669436---
additional information?-Homo sapiens-proprotein convertases play a major role in liver metastasis668083---
additional information?-Mus musculus-cleavage site specificity, activity with mutant proglucagon and truncation variants, analysis of importance of substrate domain structure, molecular modeling, overview668422---
additional information?-Caenorhabditis elegans-EGL-3/KPC2 is required for processing of FMRFamide-like peptide precursors and neuropeptide-like protein precursors688526---
additional information?-Homo sapiens-PC2 may be important in insulin and glucagon cells for processing of hormone and other protein precursors682808---
additional information?-Mus musculus-sequences with a Trp, Tyr and/or Pro in the P1' or P2' position, or a basic residue in the P3 position, are preferentially cleaved by PC2688525---

NATURAL SUBSTRATESNATURAL PRODUCTSREACTION DIAGRAMORGANISM UNIPROT ACCESSION NO.COMMENTARY SUBSTRATELITERATURE
(Substrate)
COMMENTARY PRODUCTLITERATURE
(Product)
pro-cholecystokinin + H2ON-terminal propeptide + C-terminal cholecystokinin 8 Gly Arg Arg peptide + remaining CCK peptide
show the reaction diagram
Mus musculus-the substrate is only cleaved in vivo since defolding proteins are required, in vitro the cleavage site is inaccessible for the enzyme670480peptide product analysis-
pro-islet amyloid polypeptide + H2Oislet amyloid polypeptide processing intermediate + N-terminal pro-peptide
show the reaction diagram
Mus musculus-precursor of IAPP or amylin, the major component of islet amyloid, cleavage at the N-terminus, but not the C-terminus, which would also be required for activation, the complete activation is catalyzed by PC1, EC 3.4.21.93668377--
proenkephalin + H2Oopioid-active enkephalin + ?
show the reaction diagram
Mus musculus--651994-651994
proenkephalin + H2Oopioid-active enkephalin + ?
show the reaction diagram
Mus musculus-cleaves prohormones and proneuropeptides from inactive large precursors to generate activre peptide for extracellular release651892-651892
Proglucagon + H2O?
show the reaction diagram
Mus musculus--717856--
Proglucagon + H2O?
show the reaction diagram
Mammalia-key endoprotease responsible for proglucagon processing in cells with the alpha-cell phenotype29875--
prothyrotropin-releasing hormone + H2Othyrotropin-releasing hormone + pro-peptide of thyrotropin-releasing hormone
show the reaction diagram
Rattus norvegicus-processing and activation of the inactive prohormone is required for regulation of energy balance via leptin, enzyme regulation, overview669626--
additional information?-Mammalia-present on secretory pathway of neuroendocrine cells29875--
additional information?-Homo sapiens-processing of precursors that are routed toward secretory granules29874--
additional information?-Mus musculus-glucose-dependent insulinotropic polypeptide precursor is no substrate of PC2669436--
additional information?-Homo sapiens-proprotein convertases play a major role in liver metastasis668083--

COFACTORORGANISM UNIPROT ACCESSION NO.COMMENTARYLITERATUREIMAGE
No entries in this field

METALS and IONS ORGANISM UNIPROT ACCESSION NO.COMMENTARY LITERATURE
Ca2+Homo sapiens-optimum concentration 2.5 mM653858
Ca2+Mus musculus-dependent on669378
Ca2+Rattus norvegicus--709250

INHIBITORSORGANISM UNIPROT ACCESSION NO. COMMENTARY LITERATURE IMAGE
(2R)-1-[2-[3,5-bis(trifluoromethyl)phenyl]ethyl]-4-[(1R)-2-cyclohexyl-1-[[(2S)-2-[[(2R)-2-(cyclohexylmethyl)piperazin-1-yl]methyl]pyrrolidin-1-yl]methyl]ethyl]-2-(cyclohexylmethyl)piperazineMus musculus--700298 2D-image
(2R)-4-((R)-1-cyclohexyl-3-((S)-2-(((R)-2-(cyclohexylmethyl)piperazin-1-yl)methyl)pyrrolidin-1-yl)propan-2-yl)-2-(cyclohexylmethyl)-1-(2-(4-isobutylphenyl)propyl)piperazineMus musculus--700298 2D-image
(2R)-4-((R)-1-cyclohexyl-3-((S)-2-(((S)-2-(cyclohexylmethyl)piperazin-1-yl)methyl)pyrrolidin-1-yl)propan-2-yl)-2-(cyclohexylmethyl)-1-(2-(4-isobutylphenyl)propyl)piperazineMus musculus--700298 2D-image
(R)-1-((4-tert-butylcyclohexyl)methyl)-4-((R)-1-cyclohexyl-3-((S)-2-(((S)-2-(cyclohexylmethyl)piperazin-1-yl)methyl)pyrrolidin-1-yl)propan-2-yl)-2-(cyclohexylmethyl)piperazineMus musculus--700298 2D-image
7B2 C-terminal peptideMus musculus--651994-
7B2 CT peptideMus musculus-potent specific inhibition of PC2669378-
CT peptideRattus norvegicus-a PC2-specific inhibitor709250-
cystatin-related epidiymal spermatogenic proteinMus musculus-competitive inhibitor651008-
N-((R)-1-((2R,5R)-2,5-bis(4-hydroxybenzyl)-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazol-1-yl)-3-(4-hydroxyphenyl)propan-2-yl)-3-(3,4,5-trimethoxyphenyl)propanamideMus musculus--700298 2D-image
N-((R)-1-((2R,5R)-2,5-bis(4-hydroxybenzyl)-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazol-1-yl)-3-(4-methoxyphenyl)propan-2-yl)-3,4-dimethoxybenzamideMus musculus--700298 2D-image
N-((R)-1-((2R,5R)-2,5-bis(4-hydroxybenzyl)-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazol-1-yl)-3-(4-methoxyphenyl)propan-2-yl)-3-(3,4-dimethoxyphenyl)propanamideMus musculus--700298 2D-image
decanoyl-Arg-Val-Lys-Arg-chloromethylketoneMus musculus--677957 2D-image
additional informationRattus norvegicus-starvation reduces the serum levels of leptin which decreases PC1 expression, the effect can be reversed by administration of exogenous leptin669626-
additional informationRattus norvegicus-stable expression of antisense PC2 mRNA in rMTC 6-23 cells results in a drastic decrease in PC2 protein synthesis by more than 90%, accompanied by a marked reduction in pro-neurotensin/neuromedin N cleavage by more than 80% at sites 2, 3, and 4688466-
additional informationMus musculus-after screening 38 small-molecule positional scanning libraries against PC2, two promising chemical scaffolds are identified: bicyclic guanidines, and pyrrolidine bis-piperazines. A set of individual compounds is designed from each library and tested against PC2. Pyrrolidine bis-piperazines are irreversible, time-dependent inhibitors of PC2, exhibiting noncompetitive inhibition kinetics700298-
additional informationRattus norvegicus-oxygen and glucose deprivation inhibit the PC2 activity, the pro-PC2 maturation, and thus the neuropeptide pro-protein processing system710101-

ACTIVATING COMPOUNDORGANISM UNIPROT ACCESSION NO. COMMENTARY LITERATURE IMAGE
protein 7B2Mus musculus-pro-PC2 requires interaction with this neuroendocrine-specific protein for its maturation and activation651994-
small neuroendocrine protein 7B2Mus musculus-7B2 overexpression decreases the secretion and increases the activity of PC2 within alpha-TC6 cells717856-
additional informationRattus norvegicus-leptin stimulates the PC1 expression via STAT3 acting on the PC2 promoter669626-

KM VALUE [mM]KM VALUE [mM] MaximumSUBSTRATEORGANISM UNIPROT ACCESSION NO. COMMENTARY LITERATURE IMAGE
0.27-Ac-Arg-Phe-Ala-Arg-4-methylcoumarin 7-amideMus musculus-pH 5.0, 37°C651892 2D-image
0.26-Ac-Arg-Pro-Lys-Arg-4-methylcoumarin 7-amideMus musculus-pH 5.0, 37°C651892 2D-image
0.14-Ac-Lys-Ser-Lys-Arg-4-methylcoumarin 7-amideMus musculus-pH 5.0, 37°C651892 2D-image
0.33-Ac-Orn-Ser-Lys-Arg-4-methylcoumarin 7-amideMus musculus-pH 5.0, 37°C651892 2D-image
0.51-Boc-Gly-Arg-Arg-4-methylcoumarin 7-amideMus musculus-pH 5.0, 37°C651892 2D-image
0.44-Boc-Gly-Lys-Arg-4-methylcoumarin 7-amideMus musculus-pH 5.0, 37°C651892 2D-image
1.3-Boc-Val-Pro-Arg-4-methylcoumarin 7-amideMus musculus-pH 5.0, 37°C651892 2D-image
0.11-CBZ-Arg-Ser-Lys-Arg-4-methylcoumarin 7-amideMus musculus-pH 5.0, 37°C651892 2D-image
0.079-dynorphin A 1-17Mus musculus-pH 5.0, 37°C651913-
0.1-dynorphin AB 1-32Mus musculus-pH 5.0, 37°C651913-
0.032-pGlu-Arg-Thr-Lys-Arg-methylcoumarin amideMus musculus-pH 5.0, 37°C651913 2D-image
0.077-leumorphinMus musculus-pH 5.0, 37°C651913 2D-image
additional information-additional informationMus musculus-kinetics of wild-type and mutant enzymes669378-

TURNOVER NUMBER [1/s] TURNOVER NUMBER MAXIMUM[1/s] SUBSTRATEORGANISM UNIPROT ACCESSION NO. COMMENTARY LITERATURE IMAGE
0.6-Ac-Arg-Phe-Ala-Arg-4-methylcoumarin 7-amideMus musculus-pH 5.0, 37°C651892 2D-image
99-Ac-Arg-Pro-Lys-Arg-4-methylcoumarin 7-amideMus musculus-pH 5.0, 37°C651892 2D-image
43.8-Ac-Lys-Ser-Lys-Arg-4-methylcoumarin 7-amideMus musculus-pH 5.0, 37°C651892 2D-image
39.6-Ac-Orn-Ser-Lys-Arg-4-methylcoumarin 7-amideMus musculus-pH 5.0, 37°C651892 2D-image
1.8-Boc-Gly-Arg-Arg-4-methylcoumarin 7-amideMus musculus-pH 5.0, 37°C651892 2D-image
1.2-Boc-Gly-Lys-Arg-4-methylcoumarin 7-amideMus musculus-pH 5.0, 37°C651892 2D-image
34.2-CBZ-Arg-Ser-Lys-Arg-4-methylcoumarin 7-amideMus musculus-pH 5.0, 37°C651892 2D-image
34.2-pGlu-Arg-Thr-Lys-Arg-4-methylcoumarin 7-amideMus musculus-pH 5.0, 37°C651892 2D-image

kcat/KM VALUE [1/mMs-1]kcat/KM VALUE [1/mMs-1] MaximumSUBSTRATEORGANISM UNIPROT ACCESSION NO. COMMENTARY LITERATURE IMAGE
No entries in this field

Ki VALUE [mM]Ki VALUE [mM] MaximumINHIBITORORGANISM UNIPROT ACCESSION NO. COMMENTARY LITERATURE IMAGE
0.00054-(2R)-1-[2-[3,5-bis(trifluoromethyl)phenyl]ethyl]-4-[(1R)-2-cyclohexyl-1-[[(2S)-2-[[(2R)-2-(cyclohexylmethyl)piperazin-1-yl]methyl]pyrrolidin-1-yl]methyl]ethyl]-2-(cyclohexylmethyl)piperazineMus musculus--700298 2D-image
0.00056-(2R)-4-((R)-1-cyclohexyl-3-((S)-2-(((R)-2-(cyclohexylmethyl)piperazin-1-yl)methyl)pyrrolidin-1-yl)propan-2-yl)-2-(cyclohexylmethyl)-1-(2-(4-isobutylphenyl)propyl)piperazineMus musculus--700298 2D-image
0.00066-(2R)-4-((R)-1-cyclohexyl-3-((S)-2-(((S)-2-(cyclohexylmethyl)piperazin-1-yl)methyl)pyrrolidin-1-yl)propan-2-yl)-2-(cyclohexylmethyl)-1-(2-(4-isobutylphenyl)propyl)piperazineMus musculus--700298 2D-image
0.00059-(R)-1-((4-tert-butylcyclohexyl)methyl)-4-((R)-1-cyclohexyl-3-((S)-2-(((S)-2-(cyclohexylmethyl)piperazin-1-yl)methyl)pyrrolidin-1-yl)propan-2-yl)-2-(cyclohexylmethyl)piperazineMus musculus--700298 2D-image
0.0036-N-((R)-1-((2R,5R)-2,5-bis(4-hydroxybenzyl)-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazol-1-yl)-3-(4-hydroxyphenyl)propan-2-yl)-3-(3,4,5-trimethoxyphenyl)propanamideMus musculus--700298 2D-image
0.01-N-((R)-1-((2R,5R)-2,5-bis(4-hydroxybenzyl)-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazol-1-yl)-3-(4-methoxyphenyl)propan-2-yl)-3,4-dimethoxybenzamideMus musculus--700298 2D-image
0.0033-N-((R)-1-((2R,5R)-2,5-bis(4-hydroxybenzyl)-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazol-1-yl)-3-(4-methoxyphenyl)propan-2-yl)-3-(3,4-dimethoxyphenyl)propanamideMus musculus--700298 2D-image
2.5e-05-cystatin-related epidiymal spermatogenic proteinMus musculus-pH 5.0, 25°C651008-
additional information-additional informationMus musculus-inhibition kinetics of wild-type and mutant enzymes669378-

IC50 VALUE [mM]IC50 VALUE [mM] MaximumINHIBITORORGANISM UNIPROT ACCESSION NO. COMMENTARY LITERATURE IMAGE
No entries in this field

SPECIFIC ACTIVITY [µmol/min/mg] SPECIFIC ACTIVITY MAXIMUM ORGANISM UNIPROT ACCESSION NO. COMMENTARY LITERATURE
0.015-Mus musculus--651913

pH OPTIMUMpH MAXIMUMORGANISM UNIPROT ACCESSION NO. COMMENTARYLITERATURE
5-Mus musculus--651994
5-Mus musculus-wild-type enzyme669378
5-Mus musculus-assay at700298
5-Rattus norvegicus-assay at709250
5.5-Homo sapiens--29417, 653858
additional information-Mus musculus-pH optima of mutant enzymes, overview669378

pH RANGEpH RANGE MAXIMUMORGANISM UNIPROT ACCESSION NO.COMMENTARYLITERATURE
46Mus musculus--651994
4.56Mus musculus-pH profiles of wild-type and mutant enzymes, overview669378
58Homo sapiens--653858

TEMPERATURE OPTIMUMTEMPERATURE OPTIMUM MAXIMUMORGANISM UNIPROT ACCESSION NO.COMMENTARYLITERATURE
37-Mus musculus-assay at669378, 700298
37-Rattus norvegicus-assay at709250

TEMPERATURE RANGE TEMPERATURE MAXIMUM ORGANISM UNIPROT ACCESSION NO. COMMENTARY LITERATURE
No entries in this field

pI VALUEpI VALUE MAXIMUMORGANISM UNIPROT ACCESSION NO.COMMENTARYLITERATURE
No entries in this field

SOURCE TISSUE ORGANISM UNIPROT ACCESSION NO. COMMENTARY LITERATURE SOURCE
adenoma cellHomo sapiens-human anterior pituitary adenomas are analysed717906Manually annotated by BRENDA team
alpha-TC1.9 cellMus musculus-pancreatic alpha-cell line669436Manually annotated by BRENDA team
amygdalaMus musculus--709603Manually annotated by BRENDA team
AtT-20 cellMus musculus-pituitary gland cell line, low expression level669436Manually annotated by BRENDA team
B-cellMus musculus--668377Manually annotated by BRENDA team
bone marrow stromal stem cellRattus norvegicus-PC2 is absent in undifferentiated bone marrow stromal stem cells, its expression is initiated upon the induction of differentiation. PC2 is expressed at a relatively lower level as compared to enzymes functioning in the constitutive pathway689214Manually annotated by BRENDA team
brainOryzias latipes--668720Manually annotated by BRENDA team
brainRattus norvegicus--683932Manually annotated by BRENDA team
brainHomo sapiens, Mus musculus, Rattus norvegicus-PC2 is the most abundant PC in the brain688466Manually annotated by BRENDA team
brainRattus norvegicus-healthy and ischemic709250Manually annotated by BRENDA team
brainMus musculus--709603Manually annotated by BRENDA team
cell cultureRattus norvegicus--709250Manually annotated by BRENDA team
cerebral cortexRattus norvegicus-colocalization with somatostatin, carboxypeptidase-E and PC1 in pyramidal and non-pyramidal neurons. PC2 exhibits 30% colocalization with somatostatin and 44% with carboxypeptidase-E683932Manually annotated by BRENDA team
cerebral cortexRattus norvegicus-high PC2 protein content at early ischeic reperfusion hour, which decreases with reperfusion time709250Manually annotated by BRENDA team
colonic cancer cellHomo sapiens-primary668083Manually annotated by BRENDA team
corpus striatumMus musculus--709603Manually annotated by BRENDA team
endocrine pancreasHomo sapiens-insulin cells and glucagon cells express PC2, few somatostatin cells contain PC2, is absent from pancreatic polypeptide cells. Colocalization of PC2 with PC1/3, furin and 7B2682808Manually annotated by BRENDA team
follicleOryzias latipes-small growing ovarian follicles, oocytes668720Manually annotated by BRENDA team
ganglionHaliotis asininaB2ZSS9expression of the PC2-like enzyme in the adult ganglia of the vetigastropod708778Manually annotated by BRENDA team
hippocampusRattus norvegicus-PC2 expressed in all the regions with similar levels683932Manually annotated by BRENDA team
hippocampusMus musculus--709603Manually annotated by BRENDA team
hypothalamusRattus norvegicus--669626Manually annotated by BRENDA team
hypothalamusMus musculus--688525, 709603Manually annotated by BRENDA team
hypothalamusRattus norvegicus-the effects of short-term (24 h) and long-term (7-day) morphine treatment on the expression of hypothalamic PC1/3 and PC2 and levels of phosphorylated cyclic-AMP-response element binding protein are studied. While short-term morphine exposure down-regulates, long-term morphine exposure up-regulates cyclic-AMP-response element binding protein, PC1/3 and PC2 protein levels in the rat hypothalamus as determined by Western blot analysis700473Manually annotated by BRENDA team
insulinoma cellHomo sapiens--29417, 29877Manually annotated by BRENDA team
kidneyOryzias latipes--668720Manually annotated by BRENDA team
larvaHaliotis asininaB2ZSS9expression of the PC2-like enzyme during larval development of the vetigastropod. During trochophore and early veliger larval stages, PC2 is expressed in the vicinity of the forming ganglia of the central nervous system and parts of the putative peripheral nervous system. Later in larval development, at the time the veliger becomes competent to interact with the external environment and initiate metamorphosis, PC2 expression largely restricts to cells of the major ganglia and their commissures708778Manually annotated by BRENDA team
liverHomo sapiens-high expression level of PC2 in normal, unaffected liver668083Manually annotated by BRENDA team
nervous systemHaliotis asininaB2ZSS9during trochophore and early veliger larval stages, PC2 is expressed in the vicinity of the forming ganglia of the central nervous system and parts of the putative peripheral nervous system708778Manually annotated by BRENDA team
neuroendocrine cellHomo sapiens, Mus musculus, Rattus norvegicus--688466Manually annotated by BRENDA team
neuronRattus norvegicus-hypothalamic669626Manually annotated by BRENDA team
neuronRattus norvegicus-PC2 is confined to neurons of the deeper layer. Interneurons display stronger PC2 expression than projection neurons683932Manually annotated by BRENDA team
neuronHomo sapiens, Mus musculus, Rattus norvegicus--688466Manually annotated by BRENDA team
neuronal cellRattus norvegicus--709250Manually annotated by BRENDA team
oocyteOryzias latipes-in small growing follicles668720Manually annotated by BRENDA team
ovaryOryzias latipes-ovarian follicles668720Manually annotated by BRENDA team
pancreatic alpha cellMammalia-normal and alphaTC1-629875Manually annotated by BRENDA team
prefrontal cortexMus musculus--709603Manually annotated by BRENDA team
RGC-5 cellRattus norvegicus-ischemic retinal ganglion cells710101Manually annotated by BRENDA team
thalamusMus musculus--709603Manually annotated by BRENDA team
liver cancer cellHomo sapiens-metastase originating from colorectal cancer, 2fold reduced expression compared to healthy liver668083Manually annotated by BRENDA team
additional informationHomo sapiens-distribution in tissues29874Manually annotated by BRENDA team
additional informationRattus norvegicus-in the striatum, PC2 is uniformly expressed. In addition to neurons, some nerve fibers in striatum are also PC2 positive. PC2 exhibits 19% colocalization with somatostatin and 44% with carboxypeptidase-E in the striatum683932Manually annotated by BRENDA team
additional informationMus musculus-alpha TC1 cells express PC2, alpha TCdeltaPC2 cells do not express bioactive PC2686303Manually annotated by BRENDA team
additional informationHomo sapiens-coloDM320 cell line lacks PC2 expression688466Manually annotated by BRENDA team
additional informationRattus norvegicus-present in rMTC 6-23 cells. PC12 cells lack PC2 expression688466Manually annotated by BRENDA team
additional informationHaliotis asininaB2ZSS9PC2 tissue distributionm, overview708778Manually annotated by BRENDA team

LOCALIZATION ORGANISM UNIPROT ACCESSION NO. COMMENTARY GeneOntology No. LITERATURE SOURCE
cytoplasmHomo sapiens--5737682808Manually annotated by BRENDA team
cytoplasmRattus norvegicus--5737683932Manually annotated by BRENDA team

PDBSCOPCATHORGANISM
No entries in this field

MOLECULAR WEIGHT MOLECULAR WEIGHT MAXIMUM ORGANISM UNIPROT ACCESSION NO. COMMENTARY LITERATURE
64000-Mus musculus-bioactive PC2, Western blot analysis651994
66000-Mus musculus-Western blot analysis651994

SUBUNITS ORGANISM UNIPROT ACCESSION NO. COMMENTARY LITERATURE
?Rattus norvegicus-x * 75000, proPC2, Western blot analysis. x * 68000, mature PC2, Western blot analysis683932
?Rattus norvegicus-x * 75000, pro-PC2 form, SDS-PAGE, x * 64000, mature PC2 form, SDS-PAGE709250
additional informationOryzias latipes-the preproenzyme consists of a signal peptide, a propeptide for autocatalytic activation, a Kex2-like catalytic domain, and a P-domain668720
additional informationHomo sapiens-amino acid sequence alignment of soluble ectodomain and active site cleft, domain structures, enzyme structure modeling based on the crystal structures of furin and kexin, overview669843

POSTTRANSLATIONAL MODIFICATION ORGANISM UNIPROT ACCESSION NO. COMMENTARY LITERATURE
proteolytic modificationOryzias latipes-enzyme activation by autocatalytic cleavage of the propeptide from the preproenzyme668720
proteolytic modificationRattus norvegicus-the pro-protein convertase-2, PC2, needs to activated from a pro-PC2 form to the active PC2 form710101

Crystallization/COMMENTARY ORGANISM UNIPROT ACCESSION NO. LITERATURE
No entries in this field

pH STABILITYpH STABILITY MAXIMUM ORGANISM UNIPROT ACCESSION NO. COMMENTARY LITERATURE
No entries in this field

TEMPERATURE STABILITYTEMPERATURE STABILITY MAXIMUM ORGANISM UNIPROT ACCESSION NO. COMMENTARYLITERATURE
42.5-Mus musculus-no significant loss of PC2 activity is observed below 42.5°C651913

GENERAL STABILITYORGANISM UNIPROT ACCESSION NO.LITERATURE
No entries in this field

ORGANIC SOLVENT ORGANISM UNIPROT ACCESSION NO. COMMENTARY LITERATURE
No entries in this field

OXIDATION STABILITY ORGANISM UNIPROT ACCESSION NO. LITERATURE
No entries in this field

STORAGE STABILITY ORGANISM UNIPROT ACCESSION NO. LITERATURE
No entries in this field

Purification/COMMENTARY ORGANISM UNIPROT ACCESSION NO. LITERATURE
recombinant enzymeMus musculus-651892, 651913
recombinant PC2 wild-type and mutant S383A purified on anion-exchange column and by gel filtrationMus musculus-677957
recombinant wild-type and mutant PC2 from CHO-K1 cells by adsorption chromatographyMus musculus-669378
wild-type, partiallyMus musculus-651994

Cloned/COMMENTARY ORGANISM UNIPROT ACCESSION NO. LITERATURE
gene PC2, DNA and amino acid sequence determination and analysis, phylogenetic analysisHaliotis asininaB2ZSS9708778
-Homo sapiens-29417, 29874
cDNA construction of PC2 mutants, expressed in CHO/21-kDA 7B2 cellsMus musculus-651994
co-expression of PC2 and rat pro-islet amyloid polypeptide, proIAPP, in GH3 cells lacking the enzyme, does not lead to complete cleavage of recombinant proIAPP, but to cleavage of the C-terminal site of proIAPPMus musculus-668377
expression of wild-type and mutant PC2 in CHO-K1 cellsMus musculus-669378
gene PC2, genotyping of wild-type and haplotype and holotype PC2-deficient miceMus musculus-709603
GH3 cells or INS-1 beta-cells cotransduced with proIAPP and PC2 by adenoviral expressionMus musculus-686302
overexpressed in Chinese hamster ovary cells supertransfected with rat cDNAMus musculus-651892
overexpressed in Chinese hamster ovary cells supertransfected with rat cDNA 7B2Mus musculus-651913
pcDNA3 plasmid encoding either PC2 wild-type or mutant S383A expressed in CHO-K1/7B2 cells or AtT-20/7B2 cellsMus musculus-677957
recombinant PC2 is expressed in stably transfected CHO cellsMus musculus-700298
transient enzyme expression in enzyme-deficient rat GH4C1 cells, co-expression with wild-type and mutant proglucagon, glicentin, and/or glicentin-related polypeptide-glucagon, and oxyntomodulin from hamster, overviewMus musculus-668422
transplantation of encapsulated PC2-expressing alpha TC-1 cells with PC1/3-expressing alpha TCdeltaPC2 cells in normal mice and low-dose streptozotocin-treated miceMus musculus-686303
DNA and amino acid sequence determination and analysis, the ovarian mRNA is shorter than the mRNA from brain and kidney lacking about 300 bp just before the poly(A)+ tailOryzias latipes-668720
expression of PC2 in human 293T cells, leptin has a stimulatory effect on the PC2 promoter, which is enhanced by co-expression of STAT3, overviewRattus norvegicus-669626
stable transfection of PC2 in PC12 cellsRattus norvegicus-688466

EXPRESSION ORGANISM UNIPROT ACCESSION NO. LITERATURE
transient upregulation of the mRNA level for PC2 in cerebral cortex at an early reperfusion h in a cerebral ischemia model in ratsRattus norvegicus-709250
proPC2 levels in ischemic RCG-5 cells gradually increase with ischemia and cell death after oxygen and glucose deprivation, while PC2 activity decreasesoverviewRattus norvegicus-710101

ENGINEERINGORGANISM UNIPROT ACCESSION NO.COMMENTARYLITERATURE
A322T/S323NMus musculus-site-directed mutagenesis, the mutant shows unaltered activity, but slightly decreased sensitivity for inhibitor 7B2 CT peptide compared to the wild-type enzyme669378
D278EMus musculus-site-directed mutagenesis of the S4/S5 subsite residue, the mutant shows altered substrate preferences, increased activity and reduced sensitivity to inhibitor 7B2 CT peptide compared to the wild-type enzyme669378
N356SMus musculus-site-directed mutagenesis of the distant prime site residue, the mutant shows altered substrate preferences compared to the wild-type enzyme669378
R281G/E282RMus musculus-site-directed mutagenesis of the S6 edge residue R281, the mutant shows largely altered substrate preferences and reduced activity compared to the wild-type enzyme669378
S206KMus musculus-site-directed mutagenesis of the S1' subsite residue, inactive mutant669378
S206RMus musculus-site-directed mutagenesis of the S1' subsite residue, inactive mutant669378
S380TMus musculus-site-directed mutagenesis, the mutant shows reduced activity compared to the wild-type enzyme669378
S383AMus musculus-active site mutant, seems to be folded correctly. Is efficiently secreted as the intact zymogen in CHO-K1 cells. Its propeptide can productively insert into the mutated binding pocket without causing misfolding. In AtT-20 cells, mutant S383A is cleaved at the secondary cleavage site within the propeptide. The mutant can not be cleaved by active PC2, so that other proprotein convertases, but not PC2, may be responsible for secondary site processing. This cleavage event is pH-dependent and is inhibited by the proprotein convertase inhibitor decanoyl-Arg-Val-Lys-Arg-chloromethylketone677957
T271EMus musculus-site-directed mutagenesis of the residue separating the subsites S3 and S5, the mutant shows increased activity compared to the wild-type enzyme669378
T271NMus musculus-site-directed mutagenesis of the residue separating the subsites S3 and S5, the mutant shows unaltered activity, but slightly decreased sensitivity for inhibitor 7B2 CT peptide compared to the wild-type enzyme669378
additional informationCaenorhabditis elegans-EGL-3/KPC2 mutants, malprocessing of both FMRFamide-like peptide precursors and neuropeptide-like protein precursors688526
L341WMus musculus-site-directed mutagenesis of the residue from the far edge of subsite S2', the mutant shows increased activity, and slightly decreased sensitivity for inhibitor 7B2 CT peptide compared to the wild-type enzyme669378
additional informationMus musculus-PC2-deficient cells do not show alterations in glucose-dependent insulinotropic polypeptide precursor processing activity669436
additional informationMus musculus-islets from mice lacking PC2 and with beta-cell expression of human proIAPP develop amyloid associated with beta-cell death during 2-week culture. Rescue of PC2 expression by ex vivo transduction with Ad-PC2 restores NH(2)-terminal processing to mature IAPP and decreases both the extent of amyloid formation and the number of TUNEL-positive cells, and enhances cell survival686302
additional informationMus musculus-PC2-/- mice, brain levels of neuromedin N are reduced by more than 50% with a compensatory increase in the levels of large neuromedin N. Processing at site 2 is impaired. 20% reduction in neurotensin levels688466
additional informationMus musculus-approximately one third of peptides found in wild-type mice are not detectable in PC2 knock-out mice, and another third are present at levels ranging from 25 to 75% of wild-type levels688525
additional informationMus musculus-in PC2-null mice, basal responses and responses after a cold swim are similar to wild-type mice. After a short forced swim in warm water, PC2-null mice are significantly less responsive to the stimuli than wild-type mice, an indication of increased opioid-mediated stress-induced analgesia. Enhanced analgesia in PC2-null mice may be caused by an accumulation of opioid precursor processing intermediates with potent analgesic effects, or by loss of anti-opioid peptides689212

Renatured/COMMENTARYORGANISM UNIPROT ACCESSION NO.LITERATURE
No entries in this field

APPLICATIONORGANISM UNIPROT ACCESSION NO.COMMENTARYLITERATURE
medicineHomo sapiens-PCSK2 is a strong functional candidate for type 2 diabetes. Association with type 2 diabetes among four single nucleotide polymorphisms in an African American population. None of the single nucleotide polymorphisms are associated with age at type 2 diabetes diagnosis. A variant in the PCKS2 gene (rs2021785) appears to play a role in susceptibility to type 2 diabetes-end stage renal disease in this African American population689018
medicineMus musculus-defects in processing, sorting, and/or secretion of (pro)IAPP associated with beta-cell dysfunction in type 2 diabetes and insulinomas may result in production and secretion of elevated levels of proIAPP and its NH(2)-terminally unprocessed form, leading to intracellular and/or fibril formation and beta-cell apoptosis. Restoration of intact IAPP processing may be a potential therapeutic approach to prevent or slow (pro)IAPP-induced beta-cell apoptosis and maintain beta-cell mass in type 2 diabetes686302
medicineMus musculus-transplantation of PC2-expressing alpha-cells increases plasma glucagon levels and causes mild fasting hyperglycemia, impairs glucose tolerance, and alpha-cell hypoplasia. PC2-expressing alpha-cells neither prevent streptozotocin-induced hyperglycemia nor increased beta-cell proliferation in the context of type 1 diabetes686303
molecular biologyRattus norvegicus-the regulation of the prohormone processing system by morphine may lead to alterations in the levels of multiple bioactive hormones and may be a compensatory mechanism whereby the organism tries to restore its homeostatic hormonal milieu. The down-regulation of PC1/3, PC2 and P-CREB by short-term morphine and up-regulation by long-term morphine treatment may be a signal mediating the switch from drug use to drug abuse700473
additional informationRattus norvegicus-PC2 may be a potential target for the maturation of somatostatin683932

DISEASETITLE OF PUBLICATIONLINK TO PUBMED
AdenomaTFF3-Based Candidate Gene Discrimination of Benign and Malignant Thyroid Tumors in a Region with Borderline Iodine Deficiency. PubMed
Brain InjuriesDefective neuropeptide processing and ischemic brain injury: a study on proprotein convertase 2 and its substrate neuropeptide in ischemic brains. PubMed
Brain IschemiaDefective neuropeptide processing and ischemic brain injury: a study on proprotein convertase 2 and its substrate neuropeptide in ischemic brains. PubMed
CarcinomaRap2A Is Upregulated in Invasive Cells Dissected from Follicular Thyroid Cancer. PubMed
CarcinomaTFF3-Based Candidate Gene Discrimination of Benign and Malignant Thyroid Tumors in a Region with Borderline Iodine Deficiency. PubMed
Carcinoma, PapillaryGene profiling identifies genes specific for well-differentiated epithelial thyroid tumors. PubMed
Carcinoma, PapillaryTFF3-Based Candidate Gene Discrimination of Benign and Malignant Thyroid Tumors in a Region with Borderline Iodine Deficiency. PubMed
Diabetes MellitusAssociation of type 2 diabetes susceptibility genes (TCF7L2, SLC30A8, PCSK1 and PCSK2) and proinsulin conversion in a Chinese population. PubMed
Diabetes Mellitus, Type 2Association of the prohormone convertase 2 gene (PCSK2) on chromosome 20 with NIDDM in Japanese subjects. PubMed
Diabetes Mellitus, Type 2Association of type 2 diabetes susceptibility genes (TCF7L2, SLC30A8, PCSK1 and PCSK2) and proinsulin conversion in a Chinese population. PubMed
Myocardial InfarctionAssociation of genetic variants in SEMA3F, CLEC16A, LAMA3, and PCSK2 with myocardial infarction in Japanese individuals. PubMed
NeoplasmsDoes the 3-gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms? PubMed
NeoplasmsGene profiling identifies genes specific for well-differentiated epithelial thyroid tumors. PubMed
NeoplasmsRap2A Is Upregulated in Invasive Cells Dissected from Follicular Thyroid Cancer. PubMed
proprotein convertase 2 deficiencyGenetic deficiency for proprotein convertase subtilisin/kexin type 2 in mice is associated with decreased adiposity and protection from dietary fat-induced body weight gain. PubMed
Thyroid NoduleTFF3-Based Candidate Gene Discrimination of Benign and Malignant Thyroid Tumors in a Region with Borderline Iodine Deficiency. PubMed

REF. AUTHORS TITLE JOURNAL VOL. PAGES YEAR ORGANISMLINK TO PUBMEDSOURCE
29417Steiner, D.F.; Smeekens, S.P.; Ohagi, S.; Chan, S.J.The new enzymology of precursor processing endoproteasesJ. Biol. Chem.26723435-234381992Homo sapiens PubMed
29874Seidah, N.G.; Chretien, M.Pro-protein convertases of subtilisin/kexin familyMethods Enzymol.244175-1881994Homo sapiens PubMed
29875Rouille, Y.; Westermark, G.; Martin, S.K.; Steiner, D.F.Proglucagon is processed to glucagon by prohormone convertase PC2 in alpha TC1-6 cellsProc. Natl. Acad. Sci. USA913242-32461994Mammalia PubMed
29877Smeekens, S.P.; Steiner, D.F.Identification of a human insulinoma cDNA encoding a novel mammalian protein structurally related to the yeast dibasic processing protease Kex2J. Biol. Chem.2652997-30001990Homo sapiens PubMed
651008Cornwall, G.A.; Cameron, A.; Lindberg, I.; Hardy, D.M.; Cormier, N.; Hsia, N.The cystatin-related epididymal spermatogenic protein inhibits the serine protease prohormone convertase 2Endocrinology144901-9082003Mus musculus PubMed
651892Johanning, K.; Juliano, M.A.; Juliano, L.; Lazure, C.; Lamango, N.S.; Steiner, D.F.; Lindberg, I.Specificity of prohormone convertase 2 on proenkephalin and proenkephalin-related substratesJ. Biol. Chem.27322672-226801998Mus musculus PubMed
651913Day, R.; Lazure, C.; Basak, A.; Boudreault, A.; Limperis, P.; Dong, W.; Lindberg, I.Prodynorphin processing by proprotein convertase 2. Cleavage at single basic residues and enhanced processing in the presence of carboxypeptidase activityJ. Biol. Chem.273829-8361998Mus musculus, Rattus norvegicus PubMed
651994Apletalina, E.V.; Muller, L.; Lindberg, I.Mutations in the catalytic domain of prohormone convertase 2 result in decreased binding to 7B2 and loss of inhibition with 7B2 C-terminal peptideJ. Biol. Chem.27514667-146772000Mus musculus PubMed
653858Li, Q.L.; Naqvi, S.; Shen, X.; Liu, Y.J.; Lindberg, I.; Friedman, T.C.Prohormone convertase 2 enzymatic activity and its regulation in neuro-endocrine cells and tissuesRegul. Pept.110197-2052003Homo sapiens, Mus musculus, Rattus norvegicus PubMed
668083Tzimas, G.N.; Chevet, E.; Jenna, S.; Nguyen, D.T.; Khatib, A.M.; Marcus, V.; Zhang, Y.; Chretien, M.; Seidah, N.; Metrakos, P.Abnormal expression and processing of the proprotein convertases PC1 and PC2 in human colorectal liver metastasesBMC Cancer51492005Homo sapiens PubMed
668377Marzban, L.; Trigo-Gonzalez, G.; Zhu, X.; Rhodes, C.J.; Halban, P.A.; Steiner, D.F.; Verchere, C.B.Role of beta-cell prohormone convertase (PC)1/3 in processing of pro-islet amyloid polypeptideDiabetes53141-1482004Mus musculus PubMed
668422Dey, A.; Lipkind, G.M.; Rouille, Y.; Norrbom, C.; Stein, J.; Zhang, C.; Carroll, R.; Steiner, D.F.Significance of prohormone convertase 2, PC2, mediated initial cleavage at the proglucagon interdomain site, Lys70-Arg71, to generate glucagonEndocrinology146713-7272005Mus musculus PubMed
668720Ogiwara, K.; Shinohara, M.; Takahashi, T.Expression of proprotein convertase 2 mRNA in the ovarian follicles of the medaka, Oryzias latipesGene33779-892004Oryzias latipes PubMed
669378Kacprzak, M.M.; Than, M.E.; Juliano, L.; Juliano, M.A.; Bode, W.; Lindberg, I.Mutations of the PC2 substrate binding pocket alter enzyme specificityJ. Biol. Chem.28031850-318582005Mus musculus PubMed
669436Ugleholdt, R.; Poulsen, M.L.; Holst, P.J.; Irminger, J.C.; Orskov, C.; Pedersen, J.; Rosenkilde, M.M.; Zhu, X.; Steiner, D.F.; Holst, J.J.Prohormone convertase 1/3 is essential for processing of the glucose-dependent insulinotropic polypeptide precursorJ. Biol. Chem.28111050-110572006Mus musculus PubMed
669626Sanchez, V.C.; Goldstein, J.; Stuart, R.C.; Hovanesian, V.; Huo, L.; Munzberg, H.; Friedman, T.C.; Bjorbaek, C.; Nillni, E.A.Regulation of hypothalamic prohormone convertases 1 and 2 and effects on processing of prothyrotropin-releasing hormoneJ. Clin. Invest.114357-3692004Rattus norvegicus PubMed
669843Henrich, S.; Lindberg, I.; Bode, W.; Than, M.E.Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificityJ. Mol. Biol.345211-2272004Homo sapiens-
670480Tagen, M.B.; Beinfeld, M.C.Recombinant prohormone convertase 1 and 2 cleave purified pro cholecystokinin (CCK) and a synthetic peptide containing CCK 8 Gly Arg Arg and the carboxyl-terminal flanking peptidePeptides262530-25352005Mus musculus PubMed
677957Lee, S.N.; Kacprzak, M.M.; Day, R.; Lindberg, I.Processing and trafficking of a prohormone convertase 2 active site mutantBiochem. Biophys. Res. Commun.355825-8292007Mus musculus PubMed
682808Portela-Gomes, G.M.; Grimelius, L.; Stridsberg, M.Prohormone convertases 1/3, 2, furin and protein 7B2 (Secretogranin V) in endocrine cells of the human pancreasRegul. Pept.146117-1242008Homo sapiens PubMed
683932Billova, S.; Galanopoulou, A.S.; Seidah, N.G.; Qiu, X.; Kumar, U.Immunohistochemical expression and colocalization of somatostatin, carboxypeptidase-E and prohormone convertases 1 and 2 in rat brainNeuroscience147403-4182007Rattus norvegicus PubMed
686302Marzban, L.; Rhodes, C.J.; Steiner, D.F.; Haataja, L.; Halban, P.A.; Verchere, C.B.Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell deathDiabetes552192-22012006Mus musculus PubMed
686303Wideman, R.D.; Covey, S.D.; Webb, G.C.; Drucker, D.J.; Kieffer, T.J.A switch from prohormone convertase (PC)-2 to PC1/3 expression in transplanted alpha-cells is accompanied by differential processing of proglucagon and improved glucose homeostasis in miceDiabetes562744-27522007Mus musculus PubMed
688466Kitabgi, P.Prohormone convertases differentially process pro-neurotensin/neuromedin N in tissues and cell linesJ. Mol. Med.84628-6342006Homo sapiens, Mus musculus, Rattus norvegicus PubMed
688525Pan, H.; Che, F.Y.; Peng, B.; Steiner, D.F.; Pintar, J.E.; Fricker, L.D.The role of prohormone convertase-2 in hypothalamic neuropeptide processing: a quantitative neuropeptidomic studyJ. Neurochem.981763-17772006Mus musculus PubMed
688526Husson, S.J.; Clynen, E.; Baggerman, G.; Janssen, T.; Schoofs, L.Defective processing of neuropeptide precursors in Caenorhabditis elegans lacking proprotein convertase 2 (KPC-2/EGL-3): mutant analysis by mass spectrometryJ. Neurochem.981999-20122006Caenorhabditis elegans PubMed
689018Leak, T.S.; Keene, K.L.; Langefeld, C.D.; Gallagher, C.J.; Mychaleckyj, J.C.; Freedman, B.I.; Bowden, D.W.; Rich, S.S.; Sale, M.M.Association of the proprotein convertase subtilisin/kexin-type 2 (PCSK2) gene with type 2 diabetes in an African American populationMol. Genet. Metab.92145-1502007Homo sapiens PubMed
689212Croissandeau, G.; Wahnon, F.; Yashpal, K.; Seidah, N.G.; Coderre, T.J.; Chretien, M.; Mbikay, M.Increased stress-induced analgesia in mice lacking the proneuropeptide convertase PC2Neurosci. Lett.40671-752006Mus musculus PubMed
689214Marandi, M.; Mowla, S.J.; Tavallaei, M.; Yaghoobi, M.M.; Jafarnejad, S.M.Proprotein convertases 1 and 2 (PC1 and PC2) are expressed in neurally differentiated rat bone marrow stromal stem cells (BMSCs)Neurosci. Lett.420198-2032007Rattus norvegicus PubMed
700298Kowalska, D.; Liu, J.; Appel, J.R.; Ozawa, A.; Nefzi, A.; Mackin, R.B.; Houghten, R.A.; Lindberg, I.Synthetic small-molecule prohormone convertase 2 inhibitorsMol. Pharmacol.75617-6252009Mus musculus PubMed
700473Espinosa, V.P.; Liu, Y.; Ferrini, M.; Anghel, A.; Nie, Y.; Tripathi, P.V.; Porche, R.; Jansen, E.; Stuart, R.C.; Nillni, E.A.; Lutfy, K.; Friedman, T.C.Differential regulation of prohormone convertase 1/3, prohormone convertase 2 and phosphorylated cyclic-AMP-response element binding protein by short-term and long-term morphine treatment: implications for understanding the 'switch' to opiate addictionNeuroscience156788-7992008Rattus norvegicus PubMed
708778Cummins, S.F.; York, P.S.; Hanna, P.H.; Degnan, B.M.; Croll, R.P.Expression of prohormone convertase 2 and the generation of neuropeptides in the developing nervous system of the gastropod HaliotisInt. J. Dev. Biol.531081-10882009Haliotis asinina PubMed
709250Zhan, S.; Zhao, H.; J White, A.; Minami, M.; Pignataro, G.; Yang, T.; Zhu, X.; Lan, J.; Xiong, Z.; Steiner, D.F.; Simon, R.P.; Zhou, A.Defective neuropeptide processing and ischemic brain injury: a study on proprotein convertase 2 and its substrate neuropeptide in ischemic brainsJ. Cereb. Blood Flow Metab.29698-7062009Rattus norvegicus PubMed
709603Zhang, X.; Pan, H.; Peng, B.; Steiner, D.F.; Pintar, J.E.; Fricker, L.D.Neuropeptidomic analysis establishes a major role for prohormone convertase-2 in neuropeptide biosynthesisJ. Neurochem.1121168-11792010Mus musculus PubMed
710101Tang, S.S.; Zhang, J.H.; Liu, H.X.; Zhou, D.; Qi, R.Pro-protein convertase-2/carboxypeptidase-E mediated neuropeptide processing of RGC-5 cell after in vitro ischemiaNeurosci. Bull.257-142009Rattus norvegicus PubMed
717856Helwig, M.; Lee, S.N.; Hwang, J.R.; Ozawa, A.; Medrano, J.F.; Lindberg, I.Dynamic modulation of PC2-mediated precursor processing by 7B2: preferential effect on glucagon synthesisJ. Biol. Chem.28642504-425132011Mus musculus PubMed
717906Iino, K.; Oki, Y.; Yamashita, M.; Matsushita, F.; Hayashi, C.; Yogo, K.; Nishizawa, S.; Yamada, S.; Maekawa, M.; Sasano, H.; Nakamura, H.Possible relevance between prohormone convertase 2 expression and tumor growth in human adrenocorticotropin-producing pituitary adenomaJ. Clin. Endocrinol. Metab.954003-40112010Homo sapiens PubMed

LINKS TO OTHER DATABASES (specific for EC-Number 3.4.21.94)
ExplorEnz
ExPASy
KEGG
MetaCyc
NCBI: PubMed, Protein, Nucleotide, Structure, Genome, OMIM
IUBMB Enzyme Nomenclature
PROSITE Database of protein families and domains
SYSTERS
Protein Mutant Database
InterPro (database of protein families, domains and functional sites)